Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Sales Volume, ASP & Number of Procedure Conducted by Procedure Type, Application & End-User The global atherectomy devices market will witness a robust CAGR of 7.34%, valued at $1.02 billion in 2021, expected to appreciate and reach $2.01 billion by 2030, confirms Strategic Market Research. North America had the highest industry share of 75.83%. Atherectomy is a method that uses a catheter with a sharp blade on the end that removes plaque from a blood vessel. The patient is first sedated. The surgeon then gently inserts the catheter into the patient’s body, usually in the groin or upper thigh. The catheter is then guided gently through the blood vessels into the heart. Once the catheter is at the required position, dye is injected through the catheter into the coronary arteries. An X-ray is conducted to determine the blocked or narrowed area. The surgeon uses tiny blades or lasers attached to the end of the catheter to remove plaque. A study shows over 190,000 atherectomy procedures are performed yearly in the US. This number is expected to surge owing to the increasing prevalence of atherosclerosis among the masses. Drivers - Rising Prevalence of Diseases and Geriatric Population, Growing Preference for minimally invasive surgical procedures, and Higher Success Rate The rising prevalence of cardiovascular diseases, the growing geriatric population, and the trend towards minimally invasive treatments drive the atherectomy devices market. Atherosclerosis & other cardiovascular conditions are the leading causes of morbidity & mortality worldwide. UK's 2.6 million people have heart artery narrowing, potentially causing heart attacks or angina. The American Heart Association estimates that 16 Mn Americans have coronary artery disease, the number one killer in the US. The aging population is more exposed to these diseases due to age-related changes in arterial fitness. The growing geriatric population drives the demand for atherectomy devices. Technological advancements in atherectomy devices have made procedures safer and more effective, attracting healthcare providers and physicians to adopt atherectomy procedures. Increasing awareness and diagnostic capabilities contribute to the growing demand for atherectomy procedures, with timely detection and accurate diagnosis of atherosclerotic lesions enabling healthcare providers to recommend appropriate interventions. Overall, these factors contribute to the growing demand for atherectomy procedures as an effective treatment option for atherosclerosis, driving innovation in device development. The growing preference for minimally invasive surgical processes is a significant market driver for atherectomy devices. These procedures offer several advantages over traditional open surgeries, such as reduced trauma, faster recovery, lower complication rates & reduced healthcare costs. Patients and healthcare providers appreciate the quicker recovery, reduced postoperative pain, and shorter hospital stays associated with minimally invasive procedures. Technological advancements have also improved the effectiveness and safety of atherectomy procedures, making them more appealing to patients and healthcare providers. Patient-centric care and shared decision-making processes prioritize patient preferences, leading to healthcare providers offering atherectomy procedures and driving the demand for atherectomy devices. As the need for minimally invasive procedures continues to rise, the market for atherectomy devices is expected to grow, with manufacturers investing in R&D to meet the evolving demands of patients & healthcare providers. Restraints - High Costs, High Restenosis Rate Atherectomy devices are specialized medical instruments used to treat atherosclerosis caused by plaque buildup in arteries. These devices are popular due to their minimally invasive nature & potential benefits over traditional treatments like angioplasty. However, the cost of atherectomy devices are high due to research and development, manufacturing and technology, regulatory compliance, limited competition, and physician training and support. These costs can impact healthcare providers and patients, as they may limit their ability to acquire multiple devices or invest in the latest advancements. Additionally, patients may face higher out-of-pocket expenses or increased insurance premiums due to the costly nature of atherectomy devices, limiting access to these procedures. Addressing these cost factors would improve affordability and accessibility, allowing more patients to benefit from this advanced treatment option. The high restenosis rate is a significant market restraint for atherectomy devices, as it can lead to re-narrowing or re-occlusion of the treated artery after an atherectomy procedure. This can negatively impact patient health and increase healthcare costs. Additionally, the high restenosis rate may influence market competition among different treatment modalities for atherosclerosis. Atherectomy device manufacturers can improve patient outcomes, enhance reimbursement prospects, and strengthen their market position by addressing restenosis. Ongoing research and technological advancements in this field will play a pivotal role in reducing restenosis and expanding the utilization of atherectomy devices as an effective treatment option for atherosclerosis. Opportunities - Technological Advancements Technological advances significantly contribute to the growth and adoption of atherectomy devices, driving innovation, improving device performance, and enhancing patient outcomes. Improved device design and performance, minimally invasive approaches, combination therapies, imaging and navigation technologies, and the integration of robotics and AI offer reduced patient discomfort, shorter hospital stays, faster recovery times, and lower healthcare costs. Combination therapies, such as angioplasty, stenting & drug delivery systems, offer synergistic benefits in treating atherosclerosis, reducing restenosis risk, and optimizing patient outcomes. Integrating robotics and AI technologies in atherectomy devices provides promising opportunities for improved precision, stability, and control. Technological advancements in the atherectomy devices market provide an opportunity to proliferate the market further. Market Analysis Of Different Segments Covered in the Report Based on Type Directional Coronary Atherectomy Rotational Atherectomy Orbital Atherectomy Laser Atherectomy Based on Application Peripheral Vascular Applications Cardiovascular Applications Neurovascular Applications Based on End-User Hospitals and Surgical Centres Ambulatory Care Centres Other End Users Regional Coverage Analysis North America United States of America Canada Mexico Rest of North America Europe United Kingdom Germany France Italy Rest of Europe Asia-Pacific Japan China India Rest of APAC LAMEA Argentina Brazil UAE Rest of LAMEA Segments Analysis & Insights Based on type, the orbital atherectomy segment held the largest industry size, with almost 30% in 2020. Orbital atherectomy is an adjunctive technique used for the lesion preparation of calcified plaque. This is done to avoid percutaneous coronary intervention and peripheral percutaneous endovascular interventions. According to a research study published by the American Heart Association, the success rate of orbital atherectomy was 99%. On the other hand, the laser atherectomy market is expected to grow the fastest with a CAGR of 7% due to its suitability for clinical benefits offered and ongoing increasing developments in directional Atherectomy technology. According to a study, 24% of all atherectomy procedures were done using a laser. The peripheral vascular applications segment is expected to contribute a significant market share based on application. This segment is expected to register the maximum CAGR of 6.71% due to its attribution to increasing acceptance of atherectomy to treat cardiac and peripheral vascular diseases over the forecasted period. Based on the End-Users, the atherectomy devices market is categorized into hospitals & surgical centres, ambulatory care centres & other end users. The Hospitals and surgical centres dominate the atherectomy devices market with a revenue share of 60%, growing with a CAGR of 6.63%, poised to reach $1.21 Bn by 2030. Hospitals and surgical centres are the primary end-users of atherectomy devices due to their advanced infrastructure, multidisciplinary approach, access to skilled healthcare professionals, availability of resources and support services, involvement in research and education, referral networks, and expertise in reimbursement and insurance coverage. These facilities are critical in diagnosing, treating, and managing cardiovascular diseases, including atherosclerosis, for which atherectomy procedures are performed. Hospitals & surgical centres have many resources and support services, including emergency medical services, blood banks, intensive care units, and specialized recovery units. Their active involvement in research and education drives innovation, refines techniques, and promotes the adoption of atherectomy devices. Overall, hospitals and surgical centres dominate the atherectomy devices market, driving demand and contributing to the growth and development of the market. The North American region had the highest market share of 75.83%. The rising number of cardiovascular, neurovascular, and peripheral diseases, better technology, and more trained medical professionals in atherectomy contributed to the industry's growth. According to the CDC, around 6.5 million people aged 40 and older have peripheral artery disease in the USA. Asia-Pacific is forecasted to have the maximum industry growth from 2020 to 2030, with a CAGR of 8.2%. Socioeconomic changes, unhealthy diet, liquor intake, smoking, and demographic aging have increased target diseases and increased demand for the overall market. According to an NCBI study, 4.77 million Indians will have cardiovascular diseases in 2020. Atherectomy Devices Market Report Coverage Report Attribute Details Forecast Period 2021 - 2030 The market size value in 2021 USD 1.02 billion The revenue forecast in 2030 USD 2.01 billion Growth rate CAGR of approximately 7.34% The base year for estimation 2021 Historical data 2017 – 2020 Unit USD Billion, CAGR (2021 - 2030) Segmentation By Type, By Application, By End-Use, By Region By Type Directional Atherectomy, Rotational Atherectomy, Orbital Atherectomy, Laser Atherectomy By Application Peripheral Vascular Applications, Cardiovascular Applications, Neurovascular Applications By End-Use Hospitals and Surgical Centres, Ambulatory Care Centres, Other End Users By Region Asia Pacific, North America, Europe, LAMEA Country Scope United States of America, Canada, Mexico, United Kingdom, Germany, France, Italy, Japan, India, China, Argentina, Brazil, United Arab Emirates Company Usability Profiles Abbott Laboratories, Boston Scientific Corporation, Medtronic, Becton, Dickinson and Company (BD Interventional), Koninklijke Philips N.V., Avinger, Inc., Rex Medical, AngioDynamics Cost & acquiring options Get hold of customized purchase options to fulfill your niche research needs. Atherectomy Devices Market Competitive Landscape Analysis The industry is moderately competitive, with many key players in the market. Some major companies that are currently operating in this market are: Abbott Laboratories Boston Scientific Corporation Medtronic Becton, Dickinson, and Company (BD Interventional) Koninklijke Philips N.V. Avinger, Inc. Rex Medical AngioDynamics Recent Developments On June 2023, Avinger, Inc. received FDA clearance for Pantheris LV, its next-generation image-guided atherectomy system for treating peripheral artery disease (PAD). The system offers new features, including higher cutter speeds, plaque apposition design, and enhanced torque feedback. It will be limitedly launched by the end of the quarter and expand to full commercial availability in the second half of 2023. Avinger's Lumivascular technology uses optical coherence tomography (OCT) images to guide treatment, ensuring safe and effective outcomes without ionizing radiation exposure. On February 2023, Abbott acquired Cardiovascular Systems, a prominent medical device company known for its cutting-edge atherectomy system designed to address peripheral & coronary artery disease. Under the terms of the agreement, CSI stockholders will receive a cash consideration of $20/common share, resulting in an anticipated equity value of $890 Mn. CSI is a renowned industry leader in the field of atherectomy devices. These devices are designed to optimize the advantages of standard balloon angioplasty & stent treatments, particularly in cases involving intricate arterial diseases. The acquisition will enhance Abbott's portfolio of vascular devices by incorporating complementary technologies. Various Leading Atherectomy Devices that Key Market Leaders Develop Name of the Product Function Key Player Auryon Atherectomy System Catheter Treatment of above-the-knee calcified lesions AngioDynamics Pantheris Image-Guided Atherectomy Avinger, Inc. Crosser Catheter S6 Facilitates intraluminal placement of conventional guidewires beyond peripheral artery chronic total occlusions (CTO) via atherectomy Becton, Dickinson, and Company (BD Interventional) Turbo-Elite Laser Atherectomy Catheter Treatment of multiple lesion morphologies within PAD lesions using ultraviolet radiation Koninklijke Philips NV Revolutionary Peripheral Atherectomy System Ablation and removal of thrombus and atherosclerotic plaque from peripheral arteries Rex Medical, Inc. Frequently Asked Question About This Report What are the types of atherectomy? The types of atherectomy are directional, rotational, orbital, and laser atherectomy. What is the success rate for atherectomy? The success rate of atherectomy was found to be greater than 96%. What is the atherectomy devices market growth? The global atherectomy devices market is expected to grow at a compound annual growth rate (CAGR) of 7.34% from 2021 to 2030 to reach USD2.01 billion by 2030. What is orbital atherectomy? Orbital atherectomy is an adjunctive process used to prepare lesions before percutaneous coronary infection and peripheral percutaneous endovascular intervention. How big is the atherectomy devices market? The global atherectomy devices market size was $1.06 Bn in 2021 and is predicted to reach $2.01 Bn by 2030, with a CAGR of 7.34%. What are atherectomy devices? Atherectomy devices are those devices that are used to remove the thrombus and plaque from a blood vessel. Why is the laser product segment across the market witnessing significant expansion? The laser product segment across the market is witnessing significant expansion because it is found to be suitable for clinical benefits offered and the ongoing increasing developments of directional atherectomy technology. Sources https://www.ahajournals.org/doi/10.1161/01.cir.102.21.2593 https://www.healthline.com/health/vitrectomy https://www.ncbi.nlm.nih.gov/books/NBK557482/ https://www150.statcan.gc.ca/n1/daily-quotidien/220822/dq220822b-eng.htm https://www.ahajournals.org/doi/10.1161/01.CIR.96.1.128 https://www.dicardiology.com/content/abbott-acquire-cardiovascular-systems-inc https://finance.yahoo.com/news/avinger-receives-510-k-clearance-120000796.html https://www.pandct.com/news/high-speed-brushless-motor-enhances-atherectomy-procedures-for-medical-device-manufacturer https://www.hopkinsmedicine.org/health/conditions-and-diseases/coronary-heart-disease 1. Introduction 1.1. Study Objective 1.2. Market Definition 1.3. Study Scope 1.3.1. Markets Covered 1.3.2. Geographic Scope 1.3.3. Years Considered 1.3.4. Stakeholders 2. Research Methodology 2.1. Data Procurement 2.2. Paid Database 2.2.1. Secondary Data 2.2.1.1. Key Secondary sources 2.2.2. Primary Data 2.2.2.1 Primary sources 2.2.2.2. Key industry insights 2.2.2.3. Primary interviews with experts 2.2.2.4. Key primary respondent list 2.3. Market Size Estimation 2.4. Bottom-Up and Top-Down Approaches 2.4.1. Bottom-Up Approach 2.4.1.1. Approach for arriving at market size by bottom-up analysis 2.4.2. Top-Down Approach 2.4.2.1. Approach for Capturing Market Size by Top-Down Analysis 2.5. Market Breakdown and Data Triangulation 2.6. Research Methodology 2.7. Risk Assessment 3. Executive Summary 3.1 Market: Post-Covid-19 3.1.1 Actual Scenario 3.1.2 Pessimistic Scenario 3.1.3 Optimistic Scenario 3.1.4 Market Summary 4. Industry Outlook 4.1 Market Snapshot 4.2 Global Atherectomy Devices Market 4.2.1 Global market, 2021 – 2030 (USD Million) 4.3 Regional Business Analysis 4.3.1 Global market, by Region, 2021-2030 (USD Million) 4.4 By Type Business Analysis 4.4.1 Global market, By Type, 2021-2030 (USD Million) 4.5 By End-User Business Analysis 4.5.1 Global market, By End-User, 2021-2030 (USD Million) 4.6 Application Business Analysis 4.6.1 Global market, By Application, 2021-2030 (USD Million) 4.7 Value Chain Analysis 4.8 Market Variable Analysis 4.8.1 Market Drivers Analysis 4.8.2 Market Restraints Analysis 4.9 Business Environment Analysis Tool 4.9.1 market PEST analysis 4.9.2 market Porter’s analysis 4.10Penetration & Growth Prospect Mapping 5. Market Dynamics 5.1. Introduction 5.2. Market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.2.4. Challenges 5.3. Impact of Covid-19 On Market 5.4. Value Chain Analysis 5.5. Ecosystem 5.6. Patent Analysis 5.7. Trade Analysis 5.8. Tariff Analysis 5.9. Case Study Analysis 5.10. Porter’s Five Forces Analysis 5.10.1 Threat of New Entrants 5.10.2 Threat of Substitutes 5.10.3 Bargaining Power of Buyers 5.10.4 Bargaining Power of Suppliers 5.10.5 Degree of Competition 5.11. Application Analysis 5.11.1. Trends in Application (2014-2020) 5.11.2. Trends in Application (2021-2028) 5.12. Pricing Analysis 5.12.1. Average Price Trend Analysis (By Region, By Countries) 6. Competitive & Vendor Landscape 6.1. Company Market Share Analysis 6.2. Manufacturers Manufacturing Sites, Area Served, Product Type 6.3. Market Competitive Situation and Trends 6.4. Manufacturers Mergers & Acquisitions, Expansion Plans 7. Global Market: By Type Segment Analysis 7.1. Introduction 7.2. Sales Volume & Revenue Analysis (2021-2030) 7.3. Directional Atherectomy 7.3.1. Directional Atherectomy market, 2021-2030 (USD Million) 7.4. Rotational Atherectomy 7.4.1. Rotational Atherectomy market, 2021-2030 (USD Million) 7.5. Orbital Atherectomy 7.5.1. Orbital Atherectomy market, 2021-2030 (USD Million) 7.6. Laser Atherectomy 7.6.1. Laser Atherectomy market, 2021-2030 (USD Million) 8. Global Market: By End-User Segment Analysis 8.1. Introduction 8.2. Sales Volume & Revenue Analysis (2021-2030) 8.3. Hospitals and Surgical Centres 8.3.1. Hospitals and Surgical Centresmarket, 2021-2030 (USD Million) 8.4. Ambulatory Care Centres 8.4.1. Ambulatory Care Centresmarket, 2021-2030 (USD Million) 8.5. Other End Users 8.5.1. Other End Users market, 2021-2030 (USD Million) 9. Global Market: By Application Segment Analysis 9.1. Introduction 9.2. Sales Volume & Revenue Analysis (2021-2030) 9.3. Peripheral Vascular 9.3.1. Peripheral Vascularmarket, 2021-2030 (USD Million) 9.4. Cardiovascular 9.4.1. Cardiovascularmarket, 2021-2030 (USD Million) 9.5. Neurovascular 9.5.1. Neurovascularmarket, 2021-2030 (USD Million) 10. Global Market: Regional Outlook 10.1 North America 10.1.1. North America market, by By Type, 2021-2030 (USD Million) 10.1.2. North America market, by By End-User, 2021-2030 (USD Million) 10.1.3. North America market, by Application, 2021-2030 (USD Million) 10.1.4. North America market, by Country, 2021-2030 (USD Million) 10.1.4.1. U.S. 10.1.4.1.1. U.S. market, by By Type, 2021-2030 (USD Million) 10.1.4.1.2. U.S. market, by By End-User, 2021-2030 (USD Million) 10.1.4.1.3. U.S. market, by Application, 2021-2030 (USD Million) 10.1.4.2.Canada 10.1.4.2.1. Canada market, by By Type, 2021-2030 (USD Million) 10.1.4.2.2. Canada market, by By End-User, 2021-2030 (USD Million) 10.1.4.2.3. Canada market, by Application, 2021-2030 (USD Million) 10.2. Europe 10.2.1. Europe market, by By Type, 2021-2030 (USD Million) 10.2.2. Europe market, by By End-User, 2021-2030 (USD Million) 10.2.3. Europe market, by Application, 2021-2030 (USD Million) 10.2.4. Europe market, by country, 2021-2030 (USD Million) 10.2.4.1 U.K. 10.2.4.1.1. U.K. market, by By Type, 2021-2030 (USD Million) 10.2.4.1.2. U.K. market, by By End-User, 2021-2030 (USD Million) 10.2.4.1.3. U.K. market, by Application, 2021-2030 (USD Million) 10.2.4.2. Germany 10.2.4.2.1. Germany market, by By Type, 2021-2030 (USD Million) 10.2.4.2.2. Germany market, by By End-User, 2021-2030 (USD Million) 10.2.4.2.3. Germany market, by Application, 2021-2030 (USD Million) 10.2.4.3. France 10.2.4.3.1. France market, by By Type, 2021-2030 (USD Million) 10.2.4.3.2. France market, by By End-User, 2021-2030 (USD Million) 10.2.4.3.3. France market, by Application, 2021-2030 (USD Million) 10.2.4.4. Rest of Europe 10.2.4.4.1. Rest of Europe market, by By Type, 2021-2030 (USD Million) 10.2.4.4.2. Rest of Europe market, by By End-User, 2021-2030 (USD Million) 10.2.4.4.3. Rest of Europe market, by Application, 2021-2030 (USD Million) 10.3. Asia Pacific 10.3.1. Asia Pacific market, by By Type, 2021-2030 (USD Million) 10.3.2. Asia Pacific market, by By End-User, 2021-2030 (USD Million) 10.3.3. Asia Pacific market, by Application, 2021-2030 (USD Million) 10.3.4. Asia Pacific market, by country, 2021-2030 (USD Million) 10.3.4.1. China 10.3.4.1.1. China market, by By Type, 2021-2030 (USD Million) 10.3.4.1.2. China market, by By End-User, 2021-2030 (USD Million) 10.3.4.1.3. China market, by Application, 2021-2030 (USD Million) 10.3.4.2. India 10.3.4.2.1. India market, by By Type, 2021-2030 (USD Million) 10.3.4.2.2. India market, by By End-User, 2021-2030 (USD Million) 10.3.4.2.3. India market, by Application, 2021-2030 (USD Million) 10.3.4.3. Japan 10.3.4.3.1. Japan market, by By Type, 2021-2030 (USD Million) 10.3.4.3.2. Japan market, by By End-User, 2021-2030 (USD Million) 10.3.4.3.3. Japan market, by Application, 2021-2030 (USD Million) 10.3.4.4. South Korea 10.3.4.4.1. South Korea market, by By Type, 2021-2030 (USD Million) 10.3.4.4.2. South Korea market, by By End-User, 2021-2030 (USD Million) 10.3.4.4.3. South Korea market, by Application, 2021-2030 (USD Million) 10.3.4.5. Rest of ASIA PACIFIC 10.3.4.5.1. Rest of ASIA PACIFIC market, by By Type, 2021-2030 (USD Million) 10.3.4.5.2. Rest of ASIA PACIFIC market, by By End-User, 2021-2030 (USD Million) 10.3.4.5.3. Rest of ASIA PACIFIC market, by Application, 2021-2030 (USD Million) 10.4. Latin America 10.4.1. Latin America market, by By Type, 2021-2030 (USD Million) 10.4.2. Latin America market, by By End-User, 2021-2030 (USD Million) 10.4.3. Latin America market, by Application, 2021-2030 (USD Million) 10.4.4. Latin America market, by country, 2021-2030 (USD Million) 10.4.4.1. Brazil 10.4.4.1.1. Brazil market, by By Type, 2021-2030 (USD Million) 10.4.4.1.2. Brazil market, by By End-User, 2021-2030 (USD Million) 10.4.4.1.3. Brazil market, by Application, 2021-2030 (USD Million) 10.4.4.2. Mexico 10.4.4.2.1. Mexico market, by By Type, 2021-2030 (USD Million) 10.4.4.2.2. Mexico market, by By End-User, 2021-2030 (USD Million) 10.4.4.2.3. Mexico market, by Application, 2021-2030 (USD Million) 10.4.4.3. Rest of the Latin America 10.4.4.3.1. Rest of the Latin America market, by By Type, 2021-2030 (USD Million) 10.4.4.3.2. Rest of the Latin America market, by By End-User, 2021-2030 (USD Million) 10.4.4.3.3. Rest of the Latin America market, by Application, 2021-2030 (USD Million) 10.5. LAMEA 10.5.1. LAMEA market, by By Type, 2021-2030 (USD Million) 10.5.2. LAMEA market, by By End-User, 2021-2030 (USD Million) 10.5.3. LAMEA market, by Application, 2021-2030 (USD Million) 10.5.4. LAMEA market, by Region, 2021-2030 (USD Million) 11. Competitive Landscape 11.1 Koninklijke Philips N.V.ott LaboratoriesBoston Scientific Corporation 11.1.1. Company overview 11.1.2. Financial performance 11.1.3. ProductPortfolio Analysis 11.1.4. Business Strategy & Recent Development 11.2. MEDTRONIC 11.2.1. Company overview 11.2.2. Financial performance 11.2.3. Product Portfolio Analysis 11.2.4. Business Strategy & Recent Development 11.3. BECTON, DICKINSON AND COMPANY (BD INTERVENTIONAL) 11.3.1. Company overview 11.3.2. Financial performance 11.3.3. Product Portfolio Analysis 11.3.4. Business Strategy & Recent Development 11.4. KONINKLIJKE PHILIPS N.V. 11.4.1. Company overview 11.4.2. Financial performance 11.4.3. Product Portfolio Analysis 11.4.4. Business Strategy & Recent Development 11.5. AVINGER, INC. 11.5.1. Company overview 11.5.2. Financial performance 11.5.3. Product Portfolio Analysis 11.5.4. Business Strategy & Recent Development 11.6. Rex Medical 11.6.1. Company overview 11.6.2. Financial performance 11.6.3. Product Portfolio Analysis 11.6.4. Business Strategy & Recent Development 11.7. AngioDynamics 11.7.1. Company overview 11.7.2. Financial performance 11.7.3. Product Portfolio Analysis 11.7.4. Business Strategy & Recent Development List of Tables (48 Tables) TABLE 1. MARKET, By Type, 2021-2030 (USD Million) TABLE 2. MARKET FOR Directional Atherectomy, BY REGION, 2021-2030 (USD Million) TABLE 3. MARKET FOR Rotational Atherectomy, BY REGION, 2021-2030 (USD Million) TABLE 4. MARKET FOR Orbital Atherectomy, BY REGION, 2021-2030 (USD Million) TABLE 5. MARKET, By End-User, 2021-2030 (USD Million) TABLE 6. MARKET FOR Hospitals and Surgical Centres, BY REGION, 2021-2030 (USD Million) TABLE 7. MARKET FOR Ambulatory Care Centres, BY REGION, 2021-2030 (USD Million) TABLE 8. MARKET FOR Other End Users, BY REGION, 2021-2030 (USD Million) TABLE 9. MARKET FOR Food & Beverages, BY REGION, 2021-2030 (USD Million) TABLE 10. MARKET FOR Others, BY REGION, 2021-2030 (USD Million) TABLE 11. MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 12. MARKET FOR Peripheral Vascular, BY REGION, 2021-2030 (USD Million) TABLE 13. MARKET FOR Cardiovascular, BY REGION, 2021-2030 (USD Million) TABLE 14. MARKET FOR Neurovascular, BY REGION, 2021-2030 (USD Million) TABLE 15. MARKET FOR Quality Testing, BY REGION, 2021-2030 (USD Million) TABLE 16. MARKET FOR Others, BY REGION, 2021-2030 (USD Million) TABLE 17. MARKET FOR Battery Powered , BY REGION, 2021-2030 (USD Million) TABLE 18. MARKET, BY REGION, 2021-2030 (USD Million) TABLE 19. NORTH AMERICA MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 20. NORTH AMERICA MARKET, By Type, 2021-2030 (USD Million) TABLE 21. NORTH AMERICA MARKET, By End-User, 2021-2030 (USD Million) TABLE 22. NORTH AMERICA MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 23. EUROPE MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 24. EUROPE MARKET, By Type, 2021-2030 (USD Million) TABLE 25. EUROPE MARKET, By End-User, 2021-2030 (USD Million) TABLE 26. EUROPE MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 27. ASIA-PACIFIC MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 28. ASIA-PACIFIC MARKET, By Type, 2021-2030 (USD Million) TABLE 29. ASIA-PACIFIC MARKET, By End-User, 2021-2030 (USD Million) TABLE 30. ASIA-PACIFIC MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 31. LALAMEA MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 32. LALAMEA MARKET, By Type, 2021-2030 (USD Million) TABLE 33. LALAMEA MARKET, By End-User, 2021-2030 (USD Million) TABLE 34. LALAMEA MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 35. Koninklijke Philips N.V.ott LaboratoriesBoston Scientific Corporation: COMPANY SNAPSHOT TABLE 36. Koninklijke Philips N.V.ott LaboratoriesBoston Scientific Corporation: OPERATING SEGMENTS TABLE 37. MEDTRONIC: COMPANY SNAPSHOT TABLE 38. MEDTRONIC: OPERATING SEGMENTS TABLE 39. BECTON, DICKINSON AND COMPANY (BD INTERVENTIONAL): COMPANY SNAPSHOT TABLE 40. BECTON, DICKINSON AND COMPANY (BD INTERVENTIONAL): OPERATING SEGMENTS TABLE 41. KONINKLIJKE PHILIPS N.V. : COMPANY SNAPSHOT TABLE 42. KONINKLIJKE PHILIPS N.V. : OPERATING SEGMENTS TABLE 43. AVINGER, INC.: COMPANY SNAPSHOT TABLE 44. AVINGER, INC.: OPERATING SEGMENTS TABLE 45. Rex Medical: COMPANY SNAPSHOT TABLE 46. Rex Medical: OPERATING SEGMENTS TABLE 47. AngioDynamics: COMPANY SNAPSHOT TABLE 48. AngioDynamics: OPERATING SEGMENTS List of Figures (22 Figures) Figure 1 Market: Research Methodology Steps Figure 2 Research Design Figure 3 Breakdown of Primaries: Market Figure 4 Research Methodology: Hypothesis Building Figure 5 Market: Product-Based Estimation Figure 6 Top 7 Companies with Highest No. Of Patent in Last 9 Years Figure 7 No. Of Patents Granted Per Year, 2019–2020 Figure 8 Import Data for , By Country, 2016–2020 (USD Thousand) Figure 9 Export Data for , By Country, 2016–2020 (USD Thousand) Figure 10 Data Triangulation Methodology Figure 11 Market, By End-User, 2019 vs. 2025 (USD Million) Figure 12 Market Share, By Application, 2019 vs. 2025 (USD Million) Figure 13 Market Share, By Type, 2019 vs. 2025 (USD Million) Figure 14 Geographical Snapshot of the Market Figure 15 Orbital Atherectomy to Witness Higher CAGR in the Market for Type Segment during Forecast Period. Figure 16 Peripheral Vascular to Witness Higher CAGR in the Market for Application Segment during Forecast Period. Figure 17 Hospitals and Surgical Centres to Witness Higher CAGR in the Market for End-User Segment during Forecast Period. Figure 18 APAC Region Accounted for the Largest Share of the Market, By Regional Basis, in 2019 Figure 19 Market: Drivers, Restraints, Opportunities, and Challenges Figure 20 North America: Market Snapshot Figure 21 Asia Pacific: Market Snapshot Figure 22 Vendor Dive: Evaluation Overview